KLK6 and amyloidosis: However, it cannot be ruled out, that the association of CSF-KLK6 with the CSF-pTau protein concentrations is pointing to an involvement in AD pathophysiology, as the following discussion suggests: CSF-KLK6 levels are significantly increased in patients with AD with amyloid positivity and elevated CSF-pTau (A+/T+/N+), the latter a marker specific for neurofibrillary tangles [57], but not in patients with AD with amyloid positivity and normal CSF-pTau levels (A+/T−/N+) or NC (A−/T−/N-).